ITTACc is ANZGOG’s phase II, randomised multi-centre non-comparative trial of sitravatinib in recurrent or metastatic cervical cancer that have progressed after standard therapies. ANZGOG spoke with ITTACc Principal Investigator, Dr Jeffrey Goh, who explained the study [...]
A significant international study in cervical cancer treatment, the ANZGOG-led OUTBACK trial will be presented at the 2021 ASCO Annual Meeting Plenary Session to reveal its highly anticipated results. OUTBACK is an academic collaboration [...]
In recent news, the American Society of Clinical Oncology (ASCO) has selected OUTBACK, an ANZGOG cervical cancer study, to be presented during the Plenary Session at their upcoming 2021 Annual Meeting. OUTBACK is an international trial [...]
Human papillomavirus (HPV) is a major risk factor for the development of cervical cancer. 4 March is International HPV Awareness Day, and many people are still not aware of the help available in avoiding HPV and cervical [...]
Assoc Prof Alison Brand AM spoke to Dr Norman Swan - the host of ABC Radio’s program Health Report - commenting on a recent paper in the New England Journal of Medicine about gene sequencing and [...]
Yvette was diagnosed with sarcomatous carcinoma, a rare cervical cancer earlier in 2019. She is an advocate for cervical cancer awareness and calls for women to take responsibility for their health during National Cervical Cancer Awareness [...]
The COVID-19 pandemic has presented countless challenges for the healthcare sector, including the ongoing provision of clinical trials. Medical Oncologist and ANZGOG member Dr Allison Black explains her experience with telehealth clinical trials. As part of [...]
Dr Jeffrey Goh, Chair of the ANZGOG Cervical Cancer Tumour Type Working Group, shares updates from the recent meeting on new concepts for trial developments and ITTACc trial status. Dr Jeffrey Goh is a Senior [...]
Australia New Zealand Gynaecological Oncology Group www.anzgog.org.au
Level 6, Lifehouse, 119-143 Missenden Road Camperdown NSW 2050 T:+61 2 8071 4880
E: contact@anzgog.org.au © 2024 ANZGOG | Copyright | Disclaimer | ANZGOG Policies | Whistleblower
Virtually every advance in cancer survival has been made on the back of clinical trials.
As the peak, national gynaecological cancer clinical trials organisation for Australia and New Zealand, ANZGOG‘s purpose is to improve outcomes and quality of life for women with gynaecological cancer by conducting research.
We conduct and promote clinical trials and undertake multidisciplinary research into the causes, prevention and treatments of gynaecological cancers.
Research Community Volunteers will have the opportunity to contribute to ANZGOG research at every stage of the development process.
Community volunteers will lend their voices to research discussions sharing their personal perspective and representing the broader views of people with lived experience of gynaecological cancer.
Opportunities range from sharing your lived experience as a participant on a research grant working party or a Trial Management Committee, through to Research Advisor and Expert roles requiring additional levels of education and expertise in research analysis.
Gynaecological cancer research is critically needed but critically underfunded. WomenCan is the fundraising arm of ANZGOG, supporting ANZGOG by funding our programs to improve life for women with gynaecological cancer.
WomenCan’s mission is to engage the community to fund pioneering discoveries that will enable women with a gynaecological cancer to live better and live longer.
WomenCan believes the power of the collective, united in a common purpose, can make a real difference in the lives of women with gynaecological cancers.
ANZGOG’s Survivors Teaching Students (STS) Program is a ground-breaking volunteer program that brings gynaecological cancer survivors and caregivers into the classrooms of health professional students to teach them about women’s experiences with the diseases.
Survivors and caregivers are in a unique position to help students understand the ‘lived experience’ of a gynaecological cancer, including the psychosocial impact, and the importance of timely diagnosis, good health communication and compassionate care.
By joining STS and sharing your story, you will have the opportunity to impact the future care of women diagnosed with a gynaecological cancer, with participating students reporting not only increased understanding of gynaecological cancers but also a deeper understanding of the patient experience to take forward into their practice.
Since the program began at ANZGOG in 2017, our volunteers have shared their stories with more than 11,000 students across Australia and New Zealand.
